NeueHealth (NEUE) CFO Matushak acquired 978 shares
Stocks in this Quantisnow insightHealth Care
Insider transactions reported
Jay Matushak (Chief Financial Officer at NeueHealth Inc., NEUE) reported that they acquired 978 shares on May 9, 2025. After these transactions the filing shows 41,028 shares held directly.
- Reporting person
- Matushak Jay
- Role
- Chief Financial Officer
| Date | Type | Security | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|
| May 9, 2025 | Exercise or conversion of a derivative (M) | Common Stock1 | +978 | - | - | 41,028 direct |
Options and other derivatives
| Date | Type | Security | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|
| May 9, 2025 | Exercise or conversion of a derivative (M) | Restricted Stock UnitsOn 978 Common Stock1, 2 | -978 | - | - | 0 direct |
Holdings before and after
- Common Stock: 40,050 to 41,028 direct
- Restricted Stock Units: 978 to 0 direct
Footnotes from the filing
- 1. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
- 2. These restricted stock units vested over three years as follows: (a) one-third of the original grant amount vested on May 9, 2023, (b) one-third of the original grant amount vested on May 9, 2024, (c) and one-third of the original grant amount vested on May 9, 2025.
Transaction codes in this filing
- Exercise or conversion of a derivative:
- Code M marks the exercise or conversion of an option or other derivative under an exempt plan.
FAQ
What did Matushak report in this NEUE Form 4?
Jay Matushak (Chief Financial Officer at NeueHealth Inc., NEUE) reported that they acquired 978 shares on May 9, 2025. After these transactions the filing shows 41,028 shares held directly.
How many NEUE shares does Matushak hold after this filing?
The filing shows 41,028 shares held directly after the reported transactions. Form 4 reports only the positions it lists, so this may not be every holding.
What does transaction code M mean on an SEC Form 4?
Code M marks the exercise or conversion of an option or other derivative under an exempt plan.
Historical context for NEUE
Earlier insider filings at NEUE
- Mar 18, 2025Chief Accounting Officer Scherman Jeffrey J sold $9,039 worth of shares (1,373 units at $6.58), decreasing direct ownership by 10% to 12,234 units (SEC Form 4)
- Mar 18, 2025GC & Corporate Secretary Craig Jeffery Michael sold $23,001 worth of shares (3,494 units at $6.58), decreasing direct ownership by 15% to 20,104 units (SEC Form 4)
- Mar 18, 2025EVP, Consumer Care Orozco Tomas sold $31,375 worth of shares (4,766 units at $6.58), decreasing direct ownership by 14% to 29,325 units (SEC Form 4)
- Mar 18, 2025Chief Financial Officer Matushak Jay sold $39,432 worth of shares (5,990 units at $6.58), decreasing direct ownership by 13% to 40,050 units (SEC Form 4)
- Mar 18, 2025CEO & President Mikan George Lawrence Iii sold $318,196 worth of shares (48,336 units at $6.58), decreasing direct ownership by 16% to 249,454 units (SEC Form 4)
Quantisnow market dataNYSE
NEUE
NeueHealth Inc.
- Market cap
- 30-day
- Sector
- Health Care
- Industry
- Medical Specialities
- Listed since
- 2021
Get push alerts for NEUE
Full NEUE profile on Quantisnow Follow NEUE and get a push notification the moment its next story breaks.
Original source Picked up and delivered by Quantisnow in real time